BioNTech to build factory in Jerusalem to develop and produce vaccines
BioNTech, the German biotech company that formulated the COVID vaccine sold by Pfizer, signs a memorandum of understanding to build a new facility in Jerusalem to develop and produce vaccines.
The center, to be located in the Har Hotzvim area of the capital, will focus on mRNA technologies for medications and vaccinations to fight cancer and possible future pandemics. The agreement also gives Israel the ability to be the first to purchase vaccines in the case of a pandemic outbreak.
A representative of BioNTech signs the memorandum in the capital with Jerusalem Mayor Moshe Lion, as well as Health and Finance ministry officials.